Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q14191: Variant p.Lys135Glu

Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
Gene: WRN
Feedback?
Variant information Variant position: help 135 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Lysine (K) to Glutamate (E) at position 135 (K135E, p.Lys135Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (K) to medium size and acidic (E) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In WRN. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 135 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1432 The length of the canonical sequence.
Location on the sequence: help SSMSVFPQGLKMLLENKAVK K AGVGIEGDQWKLLRDFDIKL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         SSMSVFPQGLKMLLENKAVKKAGVGIEGDQWKLLRDFDIKL

Mouse                         SSMSVFPQGLKMLLENKSIKKAGVGIEGDQWKLLRDFDVKL

Xenopus laevis                SPMAGFPKGLKRLLEDESVRKVGVGIEGDQWKLMSDYELKL

Caenorhabditis elegans        --------------DNDELPETEPESDSDKPTVTSN-----
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 1432 Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
Domain 60 – 228 3'-5' exonuclease
Region 2 – 277 Interaction with WRNIP1
Site 145 – 145 Interaction with DNA
Cross 154 – 154 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
Mutagenesis 145 – 145 W -> A. Reduces exonuclease activity.
Beta strand 133 – 139



Literature citations
The spectrum of WRN mutations in Werner syndrome patients.
Huang S.; Lee L.; Hanson N.B.; Lenaerts C.; Hoehn H.; Poot M.; Rubin C.D.; Chen D.-F.; Yang C.-C.; Juch H.; Dorn T.; Spiegel R.; Oral E.A.; Abid M.; Battisti C.; Lucci-Cordisco E.; Neri G.; Steed E.H.; Kidd A.; Isley W.; Showalter D.; Vittone J.L.; Konstantinow A.; Ring J.; Meyer P.; Wenger S.L.; Herbay A.V.; Wollina U.; Schuelke M.; Huizenga C.R.; Leistritz D.F.; Martin G.M.; Mian I.S.; Oshima J.;
Hum. Mutat. 27:558-567(2006)
Cited for: VARIANTS WRN ASN-125 AND GLU-135;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.